Navigation Links
Cord Blood America $1.6 Million in Debt Retired in Third Quarter 2009
Date:8/25/2009

SANTA MONICA, Calif., Aug. 25 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it has retired $1.6 million in debt since July 2009. The Company previously announced it retired $5 million in debt in the first half of 2009.

"We have said that one of the pillars of strength for Cord Blood America in 2009 was to significantly reduce debt and we certainly are fulfilling this obligation to our shareholders," said Matthew Schissler, founder and CEO. The Company also announced on August 5, 2009, that it retired $2.53 million of long-term debt with the payoff of two notes with the Shelter Island Opportunity Fund.

"Retirement of debt is good for our balance sheet and makes CBAI a better investment for our shareholders," said Mr. Schissler. "We are pleased with a strengthened balance sheet, having recently announced second quarter results showing a significant increase in working capital and cash on hand."

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate,'' "believe,'' "expect,'' "future,'' "intend,'' "plan,'' and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

        CONTACT:
        Paul Knopick
        E & E Communications
        949/707-5365
        pknopick@eandecommunications.com


'/>"/>
SOURCE Cord Blood America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Blood Mercury Levels Rising Among U.S. Women
2. Why thick blood protects from a heart attack
3. Give Blood Today for Community Preparedness
4. Blood test can detect brain damage in amateur boxers
5. New Omega-3 Blood Test: A Better Predictor of Coronary Heart Disease Than Cholesterol
6. Aflac Cancer Center and Blood Disorders Service of Childrens Healthcare of Atlanta Celebrates $50 Million of Goodwill
7. Blood Pressure Drug Might Work Against MS
8. Mothers Immune System May Block Fetal Treatments for Blood Diseases
9. Cord Blood America Says Balance Sheet Significantly Strengthened in 2009
10. Heroes of Chemistry for saving teeth, clean water, new high blood pressure drug
11. Bayer Statement on U.S. Food and Drug Administration Advice for Patients: Serious Errors with Certain Blood Glucose Monitoring Test Strips
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Hakim ... based healthcare technology company California Healthcom Group (CHG). , The HUG investment ... arena. With headquarters in California, CHG is a growing, internationally recognized healthcare management, ...
(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home ... world to manage stress and anxiety. , “Buzzies change the way we interact ... co-founder of Buzzies. , Since its launch date in December 2016, The TouchPoint Solution ...
(Date:3/23/2017)... Toronto,ON (PRWEB) , ... March 23, 2017 , ... ... launch of a new solution that enables organizations to easily reprint customer invoices, ... ‘PRO Reprint Server’ automates all of the steps needed to retrieve and print ...
(Date:3/23/2017)... ... March 23, 2017 , ... Altec Products, Inc. ... Group as their 2016 Microsoft Dynamics Partner of the Year at DocLink ... The award recognizes The Resource Group for their outstanding relationship with Altec and ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... for seniors, today announced rapid completion of the strategic executive team expansion needed ... notable additions to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Digital Pharmacist Inc. ( ... rapidly growing digital health company, announced today that ... allows patients to manage their prescriptions. Over three ... Denver Health Pharmacy, USave Pharmacy and Owen,s Healthcare ... Pharmacist accelerate its product development schedule, the company ...
(Date:3/23/2017)... Mar 23, 2017 Research and Markets has ... report to their offering. ... The global capillary electrophoresis market to grow at ... The report, Global Capillary Electrophoresis Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:3/23/2017)... , March 23, 2017 Newborns ... optimally to most vaccines because their young immune ... at Boston Children,s Hospital report achieving strong vaccine ... final preclinical model before human trials — by ... immune response. In two simultaneous papers, they also ...
Breaking Medicine Technology: